D 1-like receptors regulate nadph oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells

Hypertension

Volumn 53, Issue 6, 2009, Pages 1054-1061

  Li, Hewang ^a,b   Han, Weixing ^c   Van Villar, Anthony M ^a,b   Keever, Lindsay B ^a,b   Lu, Quansheng ^a,b   Hopfer, Ulrich ^d   Quinn, Mark T ^e   Felder, Robin A ^f   Jose, Pedro A ^a,b   Yu, Peiying ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MONTANA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Dopamine receptor; Lipid rafts; NADPH oxidase; Reactive oxygen species

Indexed keywords

DOPAMINE 1 RECEPTOR; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; FENOLDOPAM; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; HYPERTENSION; KIDNEY PROXIMAL TUBULE; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CELL MEMBRANE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOBLOTTING; LUMINESCENCE; METABOLISM; PROBABILITY; SENSITIVITY AND SPECIFICITY; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANALYSIS OF VARIANCE; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; FENOLDOPAM; IMMUNOBLOTTING; KIDNEY TUBULES, PROXIMAL; LUMINESCENCE; MEMBRANE MICRODOMAINS; NADPH OXIDASE; PROBABILITY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D1; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 67049095506     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.120642     Document Type: Article

References (45)

1. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
2. Quinn MT, Gauss KA. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol. 2004;76:760-781.
3. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res. 2000;87: 179-183.
4. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension. 2005;46: 943-947.
5. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of Noxl and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med. 2008;45:1340-1351.
6. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
7. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem. 2001;276:1417-1423.
8. Guzik TJ, Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of reNox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U sS A. 2000;97: 8010-8014.
9. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 2002;39:269-274.
10. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol. 2005;289:R913-R935.
11. Zuo L, Ushio-Fukai M, Hilenski LL, Alexander RW. Microtubules regulate angiotensin II type 1 receptor and Racl localization in caveo-lae/lipid rafts: role in redox signaling. Arterioscler Thromb Vasc Biol. 2004;24:1223-1228.
12. Zhan CD, Sindhu RK, Vaziri ND. Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int. 2004;65:219-227.
13. Touyz RM, Schiffrin EL. Reactive oxygen species and hypertension: a complex association. Antioxid Redox Signal. 2008;10:1041-1044.
14. Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci (Land). 2006;110:243-253.
15. Dai XL, Cao X, Kreulen DL. Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol Heart Circ Physiol. 2006;290:H1019-H1026.
16. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997; 387:569-572.
17. Smart EJ, Anderson RG. Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol. 2002;353:131-139.
18. s. J Pharmacol Exp Ther. 2000;294:407-412.
19. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007; 8:128-140.
20. 1 Dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int. 2004;66:2167-2180.
21. +-ATPase- coated endocytic vesicles in intercalated cells. J Histochem Cytochem. 1998;46:205-214.
22. Shao D, Segal AW, Dekker LV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett. 2003;550: 101-106.
23. Guichard C, Pedruzzi E, Dewas C, Fay M, Pouzet C, Bens M, Vandewalle A, Ogier-Denis E, Gougerot-Pocidalo MA, Elbim C. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem. 2005;280:37021-37032.
24. Vilhardt F, van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J. 2004;23:739-748.
25. Zhang AY, Yi F, Zhang G, Gulbins E, Li PL. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension. 2006;7:74-80.
26. Yang B, Oo TN, Rizzo V. Lipid rafts mediate H2O2 prosurvival effects in cultured endothelial cells. FASEB J. 2006;20:1501-1503.
27. Han W, Li H, Villar VA, Pascua AM, Dajani MI, Wang X, Natarajan A, Quinn MT, Felder RA, Jose PA, Yu P. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension. 2008;51(part2):481-487.
28. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens. 2002;11:87-92.
29. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood). 2003;228:134-142.
30. 1-like receptors. Circulation. 2000;101:2302-2308.
31. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006;290: R96-R104.
32. White BH, Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens. 1998;16: 1659-1665.
33. Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger JW, Douglas JG, Hopfer U. Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int. 1996;50:125-134.
34. Albrecht FE, Xu J, Moe OW, Hopfer U, Simonds WF, Orlowski J, Jose PA. Regulation of NHE3 activity by G protein subunits in renal brush-border membranes. Am J Physiol Regul Integr Comp Physiol. 2000;278: R1064-R1073.
35. Foster LJ, De Hoog CL, Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA. 2003;100:5813-5818.
36. Radeva G, Perabo J, Sharom FJ. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS J. 2005;272:4924-4937.
37. Ximenes VF, Kanegae MP, Rissato SR, Galhiane MS. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch Biochem Biophys. 2007;457:134-141.
38. Pedrosa R, Villar VA, Pascua AM, Simao S, Hopfer U, Jose PA, Soares-da-Silva P. H2O2 stimulation of the Cl-/HCO3-exchanger by angiotensin II and angiotensin II type 1 receptor distribution in membrane microdomains. Hypertension. 2008;51:1332-1338.
39. Michaely PA, Mineo C, Ying YS, Anderson RG. Polarized distribution of endogenous Racl and RhoA at the cell surface. J Biol Chem. 1999;274: 21430-21436.
40. Kumanogoh H, Miyata S, Sokawa Y, Maekawa S. Biochemical and morphological analysis on the localization of Racl in neurons. Neurosci Res. 2001;39:189-196.
41. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. Integrins regulate Rac targeting by internalization of membrane domains. Science. 2004;303:839-842.
42. Dorrance AM, Graham D, Webb RC, Fraser R, Dominiczak A. Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats. Am J Hypertens. 2001; 14:1149-1153.
43. Vázquez CM, Mate A, Angeles de la Hermosa M, Planas JM, Ruíz-Gutiérez V. Abnormalities in lipid composition of brush-border membranes isolated from renal cortex of spontaneously hypertensive rats. Am J Hypertens. 2001;14: 578-584.
44. Zeng C, Yang Z, Wang Z, Jones JE, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, Jose PA. Interaction of ATI and D5 dopamine receptors in renal proximal tubule cells. Hypertension. 2005;45: 804-810.
45. Polymeropoulos MH, Licamele L, Volpi S, Mack K, Mitkus SN, Carstea ED, Getoor L, Thompson A, Lavedan C. Common effect of antipsy-chotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia. Schizophr Res. 2009;108:134-142.